152 related articles for article (PubMed ID: 38566869)
1. Efficacy and Safety of Levetiracetam for Childhood Epilepsies.
Catibusic FH; Uzicanin S; Salihbegovic EV; Huseinbegovic Z
Med Arch; 2024; 78(2):122-126. PubMed ID: 38566869
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
[TBL] [Abstract][Full Text] [Related]
3. Levetiracetam monotherapy--outcomes from an epilepsy clinic.
Stephen LJ; Kelly K; Parker P; Brodie MJ
Seizure; 2011 Sep; 20(7):554-7. PubMed ID: 21531583
[TBL] [Abstract][Full Text] [Related]
4. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
[TBL] [Abstract][Full Text] [Related]
5. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
6. Is the anticonvulsant activity of levetiracetam dose-dependent?
Lamouret V; Kurth C; Intravooth T; Steinhoff BJ
Seizure; 2020 Dec; 83():197-202. PubMed ID: 33197757
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
[TBL] [Abstract][Full Text] [Related]
8. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011412. PubMed ID: 29243813
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.
Nevitt SJ; Sudell M; Weston J; Tudur Smith C; Marson AG
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011412. PubMed ID: 28661008
[TBL] [Abstract][Full Text] [Related]
10. Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.
Mbizvo GK; Dixon P; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001901. PubMed ID: 22972056
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With Epilepsy.
Mazur RD; Wang Ba Q; Kato Bs K; Buchsbaum Bs R; Bonito Bs J; Choi H; Hirsch L; Detyniecki K
J Child Neurol; 2019 Sep; 34(10):593-597. PubMed ID: 31113283
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.
Sands TT; Rahdari S; Oldham MS; Caminha Nunes E; Tilton N; Cilio MR
CNS Drugs; 2019 Jan; 33(1):47-60. PubMed ID: 30460546
[TBL] [Abstract][Full Text] [Related]
13. Levetiracetam-Induced Seizure Aggravation in Patients With Focal Cortical Dysplasia.
Cvetkovska E; Kuzmanovski I; Babunovska M; Boshkovski B; Aleksovska K; Trencevska GK
Clin Neuropharmacol; 2018; 41(6):218-221. PubMed ID: 30234559
[TBL] [Abstract][Full Text] [Related]
14. A Randomized Controlled Trial of Phenobarbital and Levetiracetam in Childhood Epilepsy.
Akter N; Rahman MM; Akhter S; Fatema K
Mymensingh Med J; 2018 Oct; 27(4):776-784. PubMed ID: 30487494
[TBL] [Abstract][Full Text] [Related]
15. Effects of levetiracetam on seizure frequency and neuropsychological impairments in children with refractory epilepsy with secondary bilateral synchrony.
Kanemura H; Sano F; Sugita K; Aihara M
Seizure; 2013 Jan; 22(1):43-7. PubMed ID: 23127775
[TBL] [Abstract][Full Text] [Related]
16. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
Abou-Khalil B; Hemdal P; Privitera MD
Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
[TBL] [Abstract][Full Text] [Related]
17. Levetiracetam in patients with generalised epilepsy and myoclonic seizures: an open label study.
Labate A; Colosimo E; Gambardella A; Leggio U; Ambrosio R; Quattrone A
Seizure; 2006 Apr; 15(3):214-8. PubMed ID: 16420982
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam monotherapy for the treatment of infants with epilepsy.
Arican P; Gencpinar P; Cavusoglu D; Olgac Dundar N
Seizure; 2018 Mar; 56():73-77. PubMed ID: 29453114
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
Kanemura H; Sano F; Aihara M
Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
[TBL] [Abstract][Full Text] [Related]
20. Predicting drug-resistant patients who respond to add-on therapy with levetiracetam.
Kinirons P; McCarthy M; Doherty CP; Delanty N
Seizure; 2006 Sep; 15(6):387-92. PubMed ID: 16766211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]